Tiresias: Poised

“…the Company’s development milestones over its FY24 will be closely followed by a host of other material achievements over the next 12 months and beyond.”

Robert Cooke, Non-executive Chairman, Optiscan

My friends,

The announcement of Optiscan’s collaboration with the Mayo Clinic and that the Mayo Clinic will have a financial interest in Optiscan technology in April of this year, stirred Tiresias from his slightly prolonged sabbatical to recontact with his friends. It is true that Tiresias was excited by his alma mater, the Mayo Clinic, had joined with Optiscan that Tiresias. As Tiresias wrote, “this changes everything”, and it did, and it does. Tiresias could say lot more to say, but sometimes less is more, and Tiresias would not want to become tiresome, and has decided to take another pause in his epistolary commentary. Again, Tiresias promises to return as the expected developments are announced.

So, until the next time